Teleconference Overview
The FDA Amendments of 2007 have dramatically expanded the extent of information about clinical trial protocols, adverse events and results that must be publicly registered and publicly disclosed. These new measures will affect drug, device and biotechnology sponsors of clinical research and also will significantly affect investigator-initiated research at academic medical centers and medical schools. This audioconference will describe these changes in light of the history and nature of clinical trial registry requirements.
Ropes & Gray Speakers
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.